The sale or facilitating the sale of such specified drugs shall be done only after a valid prescription of a registered practitioner is uploaded on the platform: CCPA
The CCPA said that necessary action under the provisions of the Consumer Protection Act, 2019 can be taken if the legal framework is violated
The consumer watchdog said that consuming such drugs without medical supervision could lead to severe health complications
The Central Consumer Protection Authority (CCPA) on Thursday (July 14) issued an advisory to ecommerce platforms directing them to ensure that the sale of certain Ayurvedic, Siddha and Unani drugs is only done against valid prescription.
“The CCPA has issued an advisory to ecommerce entities concerning the sale of Ayurvedic, Siddha and Unani drugs containing ingredients listed in Schedule E(1) of the Drugs and Cosmetics Rules, 1945,” the advisory said.